menu
    • menu

    Company profile for Theranexus

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders. Theranexus' unique, patented technology is aimed at increasing the efficacy of CNS drugs that have already been approved and are available on the market. Theranexus' technology is protected, unique, scalable and versatile, and used to generate high value-added proprietary drug candidate...
    Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders. Theranexus' unique, patented technology is aimed at increasing the efficacy of CNS drugs that have already been approved and are available on the market. Theranexus' technology is protected, unique, scalable and versatile, and used to generate high value-added proprietary drug candidates for different conditions, while reducing time-to-market and market entry costs and risks in comparison with standard drug development processes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TheranexusFrance Flag
    Country
    Country
    France
    Address
    Address
    60 Avenue Rockefeller Pepiniere Laennec Lyon, 69008
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.theranexus.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/theranexus
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theranexus & Beyond Batten Disease Foundation: Real-World Data
    Theranexus & Beyond Batten Disease Foundation: Real-World Data

    13 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/theranexus-and-beyond-batten-disease-foundation-announce-strong-posit-1027227

    ACCESSWIRE
    13 May 2025
    Share Share
    Theranexus & Exeltis Announce Agreement for Tx01 in Rare Disorders
    Theranexus & Exeltis Announce Agreement for Tx01 in Rare Disorders

    17 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/956406/theranexus-and-exeltis-insud-pharma-announce-licensing-agreement-to-commercialize-theranexus-tx01-for-two-rare-neurological-disorders

    ACCESSWIRE
    17 Dec 2024
    Share Share
    Theranexus Updates Cash Position and Financing Horizon
    Theranexus Updates Cash Position and Financing Horizon

    17 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/956408/theranexus-presents-an-update-of-its-cash-position-and-financing-horizon

    ACCESSWIRE
    17 Dec 2024
    Share Share
    heranexus and BBDF Win FDA Approval on Efficacy Endpoints for the PhIII Trial
    heranexus and BBDF Win FDA Approval on Efficacy Endpoints for the PhIII Trial

    09 May 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=753759&lang=en

    ACCESSWIRE
    09 May 2023
    Share Share
    Theranexus and BBDF Win FDA Approval on Efficacy Endpoints for the Ph III Trial
    Theranexus and BBDF Win FDA Approval on Efficacy Endpoints for the Ph III Trial

    09 May 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=753549&lang=en

    ACCESSWIRE
    09 May 2023
    Share Share
    Theranexus, BBDF and Cardiff University Present Their Novel Research on Batten-1
    Theranexus, BBDF and Cardiff University Present Their Novel Research on Batten-1

    21 Feb 2023

    // ACCESSWIRE

    https://www.accesswire.com/739973/Theranexus-BBDF-and-Cardiff-University-Present-Their-Novel-Research-on-Batten-1-and-Batten-Disease-at-WORLDSymposium-2023

    ACCESSWIRE
    21 Feb 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search